PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cream shows promise for stopping uncontrollable itch
Symptom relief CompletedThis study tested a cream called ruxolitinib in 190 adults with prurigo nodularis, a skin condition causing intense, persistent itching. The goal was to see if the cream safely reduces itch better than a placebo cream. Participants applied the cream daily for 12 weeks, and resear…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 17, 2026 05:07 UTC
-
New drug aims to calm relentless itch of skin disease
Symptom relief CompletedThis study tested an experimental drug called KPL-716 (vixarelimab) to see if it can reduce itching in people with prurigo nodularis, a skin condition that causes hard, itchy bumps. About 240 adults with moderate to severe itching took part. The study compared the drug to a place…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated May 17, 2026 05:06 UTC
-
New Scratch-Stopping protocol shows promise for itchy skin conditions
Symptom relief CompletedThis study tested whether a special behavior-change program (EMD-U) added to usual care improves skin-related quality of life in adults with atopic dermatitis or prurigo nodularis who scratch severely. 96 participants were randomly assigned to either the program plus usual care o…
Matched conditions: PRURIGO NODULARIS
Phase: NA • Sponsor: Tamar Nijsten • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC